Elite Pharmaceuticals Inc

Elite Pharmaceuticals Inc. a specialty pharmaceutical company engages in the development and manufacture of oral controlled-release products and generic pharmaceuticals. The company operates in two segments Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns licenses and contract manufactures various generic and oral dose pharmaceuticals products such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg 10mg 15mg 20mg and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate Amphetamine Aspartate Dextroamphetamine Sulfate and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX an immediate release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the brand Loxapine; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products. In addition it manufactures controlled-release products on a contract basis for third parties in the areas of pain allergy bariatric and infection. Further the company is developing a range of abuse deterrent opioid products. The company was incorporated in 1997 and is headquartered in Northvale New Jersey.